In this episode, UROONCO PCa Associate Editor Assoc. Prof. Pawel Rajwa (PL) interviews medical oncologist Prof. Silke Gillessen Sommer (CH) about the present and future directions of metastatic prostate cancer treatment.

They discuss the greatest survival gains in metastatic prostate cancer over the past decade, triplet therapy in mHSPC and patient selection, the role of PSMA-PET imaging and sequencing of systemic therapies in metastatic prostate cancer, biomarker-driven treatment selection, and finally where the future of metastatic prostate cancer treatment is heading.

Here are the links to the articles and event which were mentioned in this podcast:

• EORTC GUCG 2238 De-escalate trial
• CAPItello-281 phase III study
• APCCC (Advanced Prostate Cancer Consensus Conference)

For more updates on prostate cancer, please visit our educational platform UROONCO PCa.

For more EAU podcasts, please go to your favourite podcast app and subscribe to our podcast channel for regular updates: Apple Podcasts, Spotify, EAU YouTube channel.

In this episode on “Public awareness of urinary tract infections and the fight against antimicrobial resistance”, Assoc. Prof. Z. Tandoğdu (TR) is joined by Prof. G. Bonkat (CH) and Mrs. J.M. Meijlink (NL) to address one of today’s most pressing global health challenges. UTIs are among the most common bacterial infections worldwide, yet they are often wrongly perceived as minor conditions. This misconception can lead to overuse or misuse of antibiotics, fuelling the rapid spread of antimicrobial resistance.

Prof. Bonkat shares insights from the EAU Guidelines on how responsible prescribing and clinical practice can help prevent unnecessary antibiotic use. Mrs. Meijlink shares the patient perspective, stressing the importance of accurate information and clear communication between doctors and patients.

Together, the speakers explore how awareness campaigns, education, and collaboration across healthcare and patient communities are essential to reducing the burden of UTIs. They emphasise that antimicrobial resistance already causes millions of deaths each year and requires urgent, coordinated action.

The discussion highlights practical steps for clinicians and patients alike, while reminding listeners that sustainable management of UTIs depends on both medical expertise and active public involvement.

Acknowledgment

This activity is supported by an educational grant from our industry partner - GSK, with no involvement in the programme or speaker selection.

For more EAU podcasts, please go to your favourite podcast app and subscribe to our podcast channel for regular updates: Apple Podcasts, Spotify, EAU YouTube channel.

The UROONCO RCC editorial board chief editor Dr. Carmen Mir, and associate editors Dr. Teele Kuusk, Dr. Riccardo Bertolo and Assoc. Prof. Carlotta Palumbo share and discuss highlights of the important kidney cancer developments for 2025.

They summarise the developments in diagnostics and early detection, systemic therapy and perioperative treatment. They also talk about surgical and robotics innovations, tumour biology, and anticipated advances expected in 2026.

To learn more on the highlights discussed in this podcast, check out this report on kidney cancer highlights in 2025.

For more updates on kidney cancer, please visit our educational platform UROONCO RCC.

For more EAU podcasts, please go to your favourite podcast app and subscribe to our podcast channel for regular updates: Apple Podcasts, Spotify, EAU YouTube channel.